1: (ROOT (S (NP (NP (NP (NNP Coconut) (NNP Oil) (POS 's)) (NNP History)) (PP (IN in) (S (VP (VBG Destroying) (NP (NNS Viruses))))) (, ,) (VBG Including) (NP (NP (NP (NNS CoronavirusesComments)) (PP (IN by) (NP (NNP Brian) (NNP Shilhavy)))) (NP (NNP Editor))) (, ,) (NP (NML (NNP Health) (NNP Impact)) (NNP News) (NP (NNS People))) (VP (VBG living) (PP (IN in) (NP (NP (DT the) (NNPS Philippines)) (, ,) (NP (NP (DT a) (NN country)) (PP (IN of) (NP (NP (NNS islands)) (ADVP (RB not) (RB very) (RB far) (PP (IN off) (NP (NP (DT the) (NN coast)) (PP (IN of) (NP (NNP China))))))))) (, ,))))) (VP (VBP remember) (ADVP (RB all) (RB too) (RB well)) (NP (NP (DT the) (JJ last) (NN time)) (SBAR (S (NP (DT a) (JJ deadly) (NN coronavirus) (NN epidemic)) (VP (VBD broke) (PRT (RP out)) (PP (IN in) (NP (NNP China)))))))) (. .)))
2: (ROOT (S (NP (PRP It)) (VP (VBD was) (NP (CD 2003)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNP SARS) (NN coronavirus)) (VP (VBD broke) (PRT (RP out)) (PP (IN in) (NP (NNP China))))))) (. .)))
3: (ROOT (S (NP (PRP It)) (VP (VBD infected) (NP (QP (RB over) (CD 7000)) (NNS people)) (PP (IN in) (NP (NNP China))) (PP (IN with) (NP (QP (IN over) (CD 600)) (VBN recorded) (NNS deaths)))) (. .)))
4: (ROOT (S (PP (ADVP (RB Even)) (IN with) (NP (NP (NP (PRP$ its) (JJ close) (NN proximity)) (PP (IN to) (NP (NNP China)))) (CC and) (NP (NP (JJ large) (JJ Chinese) (NN population)) (PP (IN in) (NP (NP (DT the) (JJ Philippine) (NN nation)) (PP (IN of) (NP (QP (RB about) (CD 80) (CD million)) (NNS people)))))))) (, ,) (NP (NP (QP (RB only) (CD 14)) (NNS cases)) (PP (IN of) (NP (NNP SARS)))) (VP (VBD was) (VP (VBN reported) (PP (IN with) (NP (CD two) (VBN recorded) (NNS deaths))))) (. .)))
5: (ROOT (S (NP (NP (NNP Canada)) (, ,) (ADVP (NP (NP (JJ many) (NNS thousands)) (PP (IN of) (NP (NNS miles)))) (RB away)) (, ,)) (VP (VBD had) (NP (NP (NP (NP (ADJP (RB far) (JJR more)) (NNS cases)) (CC and) (NP (JJR more) (NNS deaths))) (VP (VBN recorded) (PP (IN due) (IN to) (NP (NP (NNP SARS) (NN infection)) (PP (IN from) (NP (NNP China))))))) (PP (IN than) (NP (VBG neighboring) (NNP Philippine) (NNPS Islands))))) (. .)))
6: (ROOT (S (NP (NP (CD One)) (PP (IN of) (NP (NP (NP (DT the) (NNS theories)) (VP (VBN put) (PRT (RB forward)) (PP (IN at) (NP (DT the) (NN time))))) (PP (IN as) (PP (IN to) (SBAR (WHADVP (WRB why)) (S (NP (DT the) (JJ Filipino) (NNS people)) (VP (VBD had) (NP (ADJP (RB so) (JJ few)) (NNS cases))))))))) (, ,)) (VP (VBD was) (NP (NP (NP (NP (DT the) (NN country) (POS 's)) (JJ predominant) (NN use)) (PP (IN of) (NP (NN cooking) (NN oil)))) (: :) (NP (NNP Coconut) (NNP Oil)))) (. .)))
7: (ROOT (S (NP (DT The) (NNPS Philippines)) (VP (VBZ is) (NP (NP (NP (DT the) (NN world) (POS 's)) (JJS largest) (NN producer)) (PP (IN of) (NP (NN coconut) (NN oil)))) (, ,) (PP (IN with) (S (NP (NP (QP (RB about) (CD 70)) (NN %)) (PP (IN of) (NP (NP (DT the) (NN world) (POS 's)) (NN coconut) (NN oil)))) (VP (VBG being) (VP (VBN exported) (PP (IN from) (NP (DT the) (NN country)))))))) (. .)))
8: (ROOT (S (NP (NP (DT The) (NML (JJ medium) (NN chain)) (JJ fatty) (NNS acids)) (PP (IN of) (NP (NP (NN coconut) (NN oil)) (, ,) (CC and) (ADVP (RB primarily)) (NP (JJ lauric) (NN acid)) (, ,)))) (VP (VBP have) (VP (VBN been) (VP (VBN known) (S (VP (TO to) (VB destroy) (NP (JJ enveloped) (NNS viruses)) (PP (IN by) (NP (NNS researchers))))) (PP (IN for) (NP (JJ many) (NNS years)))))) (. .)))
9: (ROOT (S (NP (NP (NP (NNP D.) (NNP Fabian) (NNP Dayrit)) (, ,) (NP (NNP P) (. ..))) (CC and) (NP (NP (NNP D.) (NNP Mary) (NNP Newport)) (, ,) (NNP ..))) (VP (VBP have) (ADVP (RB just)) (VP (VBN published) (NP (NP (DT a) (NN paper)) (VP (VBG regarding) (NP (NP (NN coconut) (NN oil) (POS 's)) (NN potential) (S (VP (TO to) (ADVP (RB also)) (VP (VB combat) (NP (NP (DT the) (JJ new) (NN coronavirus)) (VP (ADVP (RB currently)) (VBG infecting) (NP (NP (NNS people)) (PP (IN in) (NP (NNP China)))))))))))))) (. .)))
10: (ROOT (NP (NP (DT The) (NNP Potential)) (PP (IN of) (NP (NP (NNP Coconut) (NNP Oil)) (CC and) (NP (PRP$ its) (NNPS Derivatives)))) (PP (IN as) (NP (NP (ADJP (JJ Effective) (CC and) (JJ Safe)) (NNP Antiviral) (NNS Agents)) (PP (IN Against) (NP (NP (DT the) (JJ Novel) (NNP Coronavirus)) (PP (IN by) (NP (NNP Fabian))))))) (. .)))
11: (ROOT (S (SBAR (IN As) (S (NP (PRP we)) (VP (VBP write) (NP (DT this))))) (, ,) (NP (DT the) (NNP World) (NNP Health) (NNP Organization)) (VP (VBZ has) (VP (VBN declared) (NP (NP (DT a) (JJ global) (NN emergency)) (PP (IN over) (NP (NP (NP (DT the) (JJ novel) (NN coronavirus)) (, ,) (NP (CD nCo-2019)) (, ,)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN spread) (PP (IN beyond) (NP (NNP China)))))))))))) (. .)))
12: (ROOT (S (NP (EX There)) (VP (VBZ is) (ADVP (RB still)) (NP (NP (DT no) (NN cure)) (PP (IN for) (NP (CD nCo-2019))))) (. .)))
13: (ROOT (S (NP (NN nCo-2019)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN related) (PP (IN to) (NP (NP (NNP SARS)) (, ,) (NP (NP (DT a) (NN coronavirus)) (SBAR (WHNP (WDT which)) (S (VP (VBD caused) (NP (DT an) (NN outbreak)) (PP (IN in) (NP (CD 2003)))))))))))))))) (. .)))
14: (ROOT (S (S (NP (JJ Several) (NNS researchers)) (VP (VBP have) (VP (VBN been) (VP (VBG designing) (NP (NP (NNS drugs)) (SBAR (S (VP (TO to) (ADVP (RB specifically)) (VP (VB target) (NP (NP (NN protease) (NNS enzymes)) (PP (IN in) (NP (NN coronavirus))))))))))))) (, ,) (CC but) (S (NP (NP (NN testing)) (PP (IN for) (NP (DT these) (NNS drugs)))) (VP (VBZ is) (ADVP (NP (JJ many) (NNS months)) (RB away)))) (. .)))
15: (ROOT (SBARQ (WP What) (IN if) (S (NP (EX there)) (VP (VBZ is) (NP (NP (NP (DT a) (NN treatment) (NN candidate)) (PP (IN against) (NP (DT the) (NN coronavirus)))) (SBAR (SBAR (WHNP (WDT that)) (S (VP (MD might) (ADVP (RB already)) (VP (VB be) (ADJP (JJ available)))))) (CC and) (SBAR (WHNP (WP$ whose) (NN safety)) (S (VP (VBZ is) (ADVP (RB already)) (VP (VBN established))))))))) (. ?)))
16: (ROOT (S (NP (NP (NP (JJ Lauric) (NN acid)) (CC and) (NP (NN monolaurin))) (, ,) (NP (PRP$ its) (NN derivative)) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN known) (PP (IN for) (NP (JJ many) (NNS years))) (S (VP (TO to) (VP (VB have) (NP (JJ significant) (JJ antiviral) (NN activity)))))))) (. .)))
17: (ROOT (S (S (NP (JJ Lauric) (NN acid)) (VP (VBZ is) (NP (NP (DT a) (NML (NN mediu) (HYPH -) (NN chain)) (JJ fatty) (NN acid)) (SBAR (WHNP (WDT which)) (S (VP (VBZ makes) (PRT (RP up)) (NP (NP (QP (RB about) (CD 50)) (NN %)) (PP (IN of) (NP (NN coconut) (NN oil)))))))))) (: ;) (S (NP (NN monolaurin)) (VP (VBZ is) (NP (NP (DT a) (NN metabolite)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ is) (ADVP (RB naturally)) (VP (VBN produced) (PP (IN by) (NP (NP (DT the) (NN body) (POS 's)) (JJ own) (NNS enzymes))) (PP (IN upon) (NP (NP (NN ingestion)) (PP (IN of) (NP (NN coconut) (NN oil))))))) (CC and) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ available) (PP (IN in) (NP (JJ pure) (NN form))) (PP (IN as) (NP (DT a) (NN supplement))))))))))) (. .)))
18: (ROOT (S (NP (NP (NN Sodium) (NN lauryl) (NN sulfate)) (, ,) (NP (NP (DT a) (JJ common) (NN surfactant)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN made) (PP (IN from) (NP (JJ lauric) (NN acid)))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (JJ potent) (JJ antiviral) (NNS properties)))))))) (. .)))
19: (ROOT (S (NP (NP (JJ Lauric) (NN acid)) (, ,) (NP (NN monolaurin)) (, ,) (CC and) (NP (NN sodium) (NN lauryl) (NN sulfate))) (VP (VBP are) (VP (VBN used) (PP (IN in) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NNS products))))) (PP (IN for) (NP (PRP$ their) (JJ antiviral) (NNS properties))))) (. .)))
20: (ROOT (S (NP (NP (NP (NNS Mechanisms)) (PP (IN of) (NP (NN action)))) (S (NP (CD Three) (NNS mechanisms)) (VP (VBP have) (VP (VBN been) (VP (VBN proposed) (S (VP (TO to) (VP (VB explain) (NP (NP (DT the) (JJ antiviral) (NN activity)) (PP (IN of) (NP (NP (JJ lauric) (NN acid)) (CC and) (NN monolaurin)))))))))))) (: :) (S (S (ADVP (RB first)) (, ,) (NP (PRP they)) (VP (VBP cause) (NP (NP (NN disintegration)) (PP (IN of) (NP (DT the) (NN virus) (NN envelope)))))) (: ;) (S (ADVP (JJ second)) (, ,) (NP (PRP they)) (VP (MD can) (VP (VB inhibit) (NP (NP (JJ late) (NN maturation) (NN stage)) (PP (IN in) (NP (DT the) (NN virus) (JJ replicative) (NN cycle))))))) (: ;) (CC and) (S (ADVP (JJ third)) (, ,) (S (NP (PRP they)) (VP (MD can) (VP (VB prevent) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (JJ viral) (NNS proteins))) (PP (IN to) (NP (DT the) (NN host) (NN cell) (NN membrane))))))))) (. .)))
21: (ROOT (NP (NP (NN Disintegration)) (PP (IN of) (NP (DT the) (NN virus) (NN membrane))) (. .)))
22: (ROOT (S (NP (NP (DT The) (JJ antiviral) (NNS activities)) (PP (IN of) (NP (NP (JJ lauric) (NN acid)) (CC and) (NP (NN monolaurin))))) (VP (VBD were) (ADVP (RB first)) (VP (VP (VBN noted) (PP (IN by) (NP (NP (NNP Sands)) (CC and) (NP (NN c) (HYPH -) (NNS workers))))) (CC and) (ADVP (RB later)) (PP (IN by) (NP (NNP Hierholzer) (CC &) (NNP Kabara))))) (. .)))
23: (ROOT (S (PP (IN In) (ADJP (JJ particular))) (, ,) (NP (NNP Hierholzer) (CC &) (NNP Kabara)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (NN monolaurin)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB reduce) (NP (NP (NP (NN infectivity)) (PP (IN of) (NP (CD 14) (JJ human) (NML (NNP RNA)) (CC and) (ADJP (NNP DNA) (VBN enveloped)) (NNS viruses)))) (PP (IN in) (NP (NN cell) (NN culture)))) (PP (IN by) (NP (QP (IN >) (CD 9.9)) (NN %)))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NN monolaurin)) (VP (VBD acted) (PP (IN by) (S (VP (VBG disintegrating) (NP (DT the) (NN virus) (NN envelope)))))))))) (. .)))
24: (ROOT (S (NP (NP (NNP Thormar)) (CC and) (NP (NN c) (HYPH -) (NNS workers))) (VP (VBD confirmed) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (JJ lauric) (NN acid) (CC and) (NN monolaurin))) (S (VP (TO to) (VP (VB inactivate) (NP (NNS viruses)) (PP (IN by) (NP (NP (NN disintegration)) (PP (IN of) (NP (DT the) (NN cell) (NN membrane)))))))))) (. .)))
25: (ROOT (S (NP (JJ Sodium) (NN lauryl) (NN sulfate)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB solubilize) (CC and) (VB denature) (NP (DT the) (JJ viral) (NN envelope)))))))))))) (. .)))
26: (ROOT (S (VP (VBZ Inhibits) (NP (NN virus) (NN maturation))) (. .)))
27: (ROOT (S (NP (DT The) (NNP Junin) (NN virus)) (VP (VBZ is) (NP (NP (DT the) (JJ causative) (NN agent)) (PP (IN of) (NP (JJ Argentine) (JJ hemorrhagic) (NN fever))))) (. .)))
28: (ROOT (S (PP (IN In) (NP (NP (DT a) (NN comparison)) (PP (IN among) (NP (NP (DT the) (VBN saturated) (JJ fatty) (NNS acids)) (PP (PP (IN from) (NP (CD C10))) (PP (IN to) (NP (CD C18)))))) (PP (IN against) (NP (NNP JUNV) (NN infection))))) (, ,) (NP (NNP Bartolotta) (CC and) (NN c) (HYPH -) (NNS workers)) (VP (VBD showed) (SBAR (IN that) (S (NP (JJ lauric) (NN acid)) (VP (VBD was) (NP (DT the) (ADJP (RBS most) (JJ active)) (NN inhibitor)))))) (. .)))
29: (ROOT (S (PP (IN From) (NP (JJ mechanistic) (NNS studies))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN concluded) (SBAR (IN that) (S (NP (JJ lauric) (NN acid)) (VP (VBD inhibited) (NP (NP (DT a) (JJ late) (NN maturation) (NN stage)) (PP (IN in) (NP (NP (DT the) (JJ replicative) (NN cycle)) (PP (IN of) (NP (NNP JUNV))))))))))) (. .)))
30: (ROOT (S (S (PP (IN From) (NP (NN transmission) (NML (NN electron) (NN microscope)) (NNS images))) (, ,) (NP (NNP JUNV)) (VP (VBZ is) (NP (NP (DT an) (JJ enveloped) (NN virus)) (VP (VBG featuring) (NP (NP (NNS glycoproteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN embedded) (PP (IN in) (NP (NP (DT the) (NN lipid) (NN bilayer)) (VP (VBG forming) (NP (JJ viral) (NNS spikes)))))))))))))) (: ;) (S (NP (DT this)) (VP (VBZ is) (ADJP (JJ similar) (PP (IN to) (NP (CD nCo-2019)))))) (. .)))
31: (ROOT (S (VP (VBZ Prevents) (NP (NP (NN binding)) (PP (IN of) (NP (JJ viral) (NNS proteins))) (PP (IN to) (NP (DT the) (NN host) (NN cell) (NN membrane))))) (. .)))
32: (ROOT (S (S (NP (NNP Hornung) (CC and) (NN c) (HYPH -) (NNS workers)) (VP (VBD showed) (SBAR (IN that) (S (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ lauric) (NN acid))))) (, ,) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (JJ infectious) (NML (JJ vesicular) (NNS stomatitis)) (NN virus)))) (VP (VBD was) (VP (VBN inhibited) (PP (IN in) (NP (DT a) (ADJP (ADJP (NN dos) (HYPH -) (JJ dependent)) (CC and) (ADJP (JJ reversible))) (NN manner))))))))) (: :) (S (PP (IN after) (NP (NP (NN removal)) (PP (IN of) (NP (JJ lauric) (NN acid))))) (, ,) (NP (DT the) (JJ antiviral) (NN effect)) (VP (VBD disappeared))) (. .)))
33: (ROOT (S (NP (PRP They)) (VP (VBD observed) (SBAR (IN that) (S (NP (JJ lauric) (NN acid)) (VP (VP (VBD did) (RB not) (VP (VB influence) (NP (NML (JJ viral) (NN membrane)) (NN protein) (NN synthesis)))) (, ,) (CC but) (VP (VBD prevented) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (JJ viral) (NNP M) (NNS proteins))) (PP (IN to) (NP (DT the) (NN host) (NN cell) (NN membrane))))))))) (. .)))
34: (ROOT (S (SBAR (IN Although) (S (NP (JJ lauric) (NN acid)) (VP (VBZ accounts) (PP (IN for) (NP (NP (JJ much)) (PP (IN of) (NP (NP (DT the) (VBN reported) (JJ antiviral) (NN activity)) (PP (IN of) (NP (NN coconut) (NN oil)))))))))) (, ,) (NP (NP (NN capric) (NN acid)) (CC and) (NP (NN monocaprin))) (VP (VBP have) (ADVP (RB also)) (VP (VBN shown) (NP (NP (JJ promising) (NN activity)) (PP (IN against) (NP (NP (JJ other) (NNS viruses)) (, ,) (PP (JJ such) (IN as) (NP (CD HI-1)))))))) (. .)))
35: (ROOT (S (NP (NN Capric) (NN acid)) (VP (VBZ accounts) (PP (IN for) (NP (NP (QP (RB about) (CD 7)) (NN %)) (PP (IN of) (NP (NN coconut) (NN oil)))))) (. .)))
36: (ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (NP (QP (ADVP (RB at) (RBS least)) (CD two)) (JJ fatty) (NNS acids)) (PP (IN in) (NP (NN coconut) (NN oil)))) (, ,) (CC and) (NP (PRP$ their) (NNS monoglycerides)) (, ,)) (VP (VBP have) (NP (JJ antiviral) (NNS properties))) (. .)))
37: (ROOT (S (NP (NP (NNP Hilarsson)) (CC and) (NP (NN c) (HYPH -) (NNS workers))) (VP (VBD tested) (NP (NP (JJ virucidal) (NNS activities)) (PP (IN of) (NP (NP (JJ fatty) (NNS acids)) (, ,) (NP (NNS monoglycerides)) (CC and) (NP (JJ fatty) (NNS alcohols))))) (PP (IN against) (NP (NP (JJ respiratory) (JJ syncytial) (NN virus)) (CC and) (NP (NML (JJ human) (NN parainfluenza) (NN virus)) (NN type) (CD 2)))) (PP (IN at) (NP (JJ different) (NML (NML (NNS concentrations)) (, ,) (NML (NNS times)) (CC and) (NML (NN pH) (NNS levels)))))) (. .)))
38: (ROOT (S (NP (PRP They)) (VP (VBD reported) (SBAR (S (NP (NP (DT the) (ADJP (RBS most) (JJ active)) (NN compound)) (VP (VBN tested))) (VP (VBD was) (NP (NP (NN monocaprin)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB also)) (VP (VBD showed) (NP (NP (NP (NN activity)) (PP (IN against) (NP (NML (NN influenza) (NNP A)) (NN virus)))) (CC and) (NP (JJ significant) (JJ virucidal) (NNS activities))) (PP (ADVP (RB even)) (IN at) (NP (NP (DT a) (NN concentration)) (ADJP (ADJP (RB as) (JJ low)) (PP (IN as) (NP (CD .0-.12) (NN %)))))))))))))) (. .)))
39: (ROOT (S (NP (NP (NN Use)) (PP (IN of) (NP (NP (NN coconut) (NN oil)) (CC and) (NP (NNP C12) (NNS derivatives)))) (PP (PP (IN in) (NP (NNS animals) (CC and) (NNS humans))) (NP (NP (NN Coconut) (NN oil)) (CC and) (NP (PRP$ its) (NNS derivatives))))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (ADJP (JJ safe) (CC and) (JJ effective)) (JJ antiviral) (NNS compounds)) (PP (IN in) (NP (DT both) (NNS humans) (CC and) (NNS animals))))))))) (. .)))
40: (ROOT (S (PP (IN Because) (IN of) (NP (NP (DT the) (ADJP (JJ antiviral) (CC and) (JJ antibacterial)) (NN protection)) (SBAR (WHNP (WDT that)) (S (NP (PRP it)) (VP (VBZ provides) (PP (IN to) (NP (NNS animals)))))))) (, ,) (NP (NP (NN coconut) (NN oil)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ lauric) (NN acid)) (CC and) (NP (NN monolaurin))) (, ,)) (VP (VBZ is) (VP (VBN used) (PP (IN in) (NP (NN farm) (NNS animals) (CC and) (NNS pets))) (PP (IN as) (NP (NP (JJ veterinary) (NN feed) (NNS supplements)) (PP (IN in) (NP (NN chicken) (, ,) (NN swine) (CC and) (NNS dogs))))))) (. .)))
41: (ROOT (S (NP (NN Monolaurin)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (ADVP (RB effectively)) (VP (VB protect) (NP (NN chicken)) (PP (IN against) (NP (NML (JJ avian) (NN influenza)) (NN virus))))))))) (. .)))
42: (ROOT (S (NP (NNP Li) (CC and) (HYPH co-) (NNS workers)) (VP (VP (VBD prepared) (NP (NP (DT a) (NN gel)) (VP (VBG containing) (NP (NN monolaurin))))) (CC and) (VP (VBD found) (S (S (NP (PRP it)) (VP (TO to) (VP (VB be) (ADJP (RB highly) (JJ active) (PP (IN against) (NP (NP (JJ repeated) (JJ high) (JJ viral) (NNS loads)) (PP (IN of) (NP (NML (NNP Simean) (NN immunodeficiency)) (NN virus))) (PP (IN in) (NP (NNS macaques))))))))) (CC and) (S (NP (NP (NNP Kirtane)) (CC and) (NP (HYPH co-) (NNS workers))) (VP (VBD developed) (NP (NP (DT a) (NML (CD 35) (NN %)) (NN gel)) (PP (IN of) (NP (NN monolaurin)))) (PP (IN for) (NP (NP (NP (NN application)) (PP (IN in) (NP (DT the) (JJ female) (JJ genital) (NN tract)))) (S (VP (TO to) (VP (VB protect) (PP (IN against) (NP (NNP HIV))))))))))))) (. .)))
43: (ROOT (S (NP (NN Sodium) (NN lauryl) (NN sulfate)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (PP (IN at) (NP (JJ low) (NNS concentrations))) (S (VP (TO to) (VP (VB inactivate) (NP (NP (NNS viruses)) (PP (IN in) (NP (NP (NN milk)) (PP (IN of) (NP (NN farm) (NNS animals)))))))))))) (. .)))
44: (ROOT (S (NP (NNP SLS)) (VP (VP (VBZ is) (NP (NP (DT the) (JJ active) (NN constituent)) (PP (IN in) (NP (NP (JJ commercial) (NN disinfecting) (NNS wipes)) (CC and) (NP (JJ standard) (NN laboratory) (NNS disinfectants)))))) (, ,) (CC and) (VP (VBZ is) (NP (NP (DT an) (NML (NML (VBG emulsifying) (NN agent)) (CC and) (NML (NN penetration) (NN enhancer)))) (PP (IN in) (NP (JJ pharmaceutical) (NNS preparations)))))) (. .)))
